Mirati Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:26M Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Jan 24	Sell€86,526	James Christensen	Individual	1,597	€54.18
16 Jan 24	Sell€86,526	Benjamin Hickey	Individual	1,597	€54.18
08 Jan 24	Sell€112,208	Benjamin Hickey	Individual	2,090	€53.69
04 Jan 24	Sell€82,160	James Christensen	Individual	1,531	€53.66

Insider Trading Volume

Insider Buying: 26M insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 26M?
Owner Type	Number of Shares	Ownership Percentage
State or Government	20,048	0.0241%
Private Companies	289,358	0.347%
Individual Insiders	627,529	0.753%
VC/PE Firms	6,337,406	7.6%
Hedge Funds	20,832,159	25%
Institutions	55,237,641	66.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.8%.

Top Shareholders

Top 25 shareholders own 95.22% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	EcoR1 Capital, LLC	7,396,979	€399.6m	28.7%	11.41%
9.65%	RTW Investments, LP	6,768,514	€365.7m	51.3%	6.36%
9.5%	Avoro Capital Advisors LLC	6,666,666	€360.2m	20%	6.29%
9.03%	Tavistock Life Sciences	6,337,406	€342.4m	0%	15.02%
8.13%	The Vanguard Group, Inc.	5,699,632	€307.9m	14.5%	0.01%
5.05%	BlackRock, Inc.	3,544,311	€191.5m	6.82%	no data
4.73%	Wellington Management Group LLP	3,319,922	€179.4m	-2.02%	0.03%
3.91%	State Street Global Advisors, Inc.	2,745,968	€148.4m	6.36%	0.01%
3.47%	T. Rowe Price Group, Inc.	2,433,029	€131.5m	36.9%	0.01%
3.39%	Morgan Stanley, Investment Banking and Brokerage Investments	2,378,469	€128.5m	-14.8%	0.02%
2.89%	Artal Group S.A.	2,024,226	€109.4m	-1.51%	3.51%
2.79%	OrbiMed Advisors LLC	1,959,050	€105.8m	114%	1.7%
2.38%	Paradigm Biocapital Advisors LP	1,668,116	€90.1m	15.5%	4.76%
2.18%	FMR LLC	1,527,739	€82.5m	1,130%	0.01%
2.14%	Camber Capital Management LP	1,500,000	€81.0m	-16.7%	2.82%
2.01%	Baker Bros. Advisors LP	1,409,784	€76.2m	0%	0.9%
1.94%	Armistice Capital LLC	1,364,098	€73.7m	-65.7%	2.07%
1.68%	Adage Capital Management, L.P.	1,175,000	€63.5m	0%	0.14%
1.61%	Citadel Advisors LLC	1,131,438	€61.1m	135%	0.07%
1.61%	Rock Springs Capital Management LP	1,131,207	€61.1m	0.85%	1.67%
1.48%	Fiera Capital Corporation	1,038,836	€56.1m	50.1%	0.14%
1.43%	Farallon Capital Management, L.L.C.	1,001,000	€54.1m	0%	0.4%
1.27%	Candriam, société en commandite par actions	893,763	€48.3m	2.29%	0.16%
1.26%	Geode Capital Management, LLC	881,226	€47.6m	15.3%	no data
1.13%	Franklin Resources, Inc.	795,730	€43.0m	23%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/01/23 14:43
End of Day Share Price	2024/01/23 00:00
Earnings	2023/09/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mirati Therapeutics, Inc. is covered by 31 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Huidong Wang	Barclays
George Farmer	BMO Capital Markets Equity Research
Jason Matthew Gerberry	BofA Global Research